Which Health-Related Quality of Life Items Most Affect Acne Patients?


Journal

Dermatology (Basel, Switzerland)
ISSN: 1421-9832
Titre abrégé: Dermatology
Pays: Switzerland
ID NLM: 9203244

Informations de publication

Date de publication:
2023
Historique:
received: 17 05 2022
accepted: 06 08 2022
pubmed: 9 12 2022
medline: 7 3 2023
entrez: 8 12 2022
Statut: ppublish

Résumé

Health-related quality of life (HRQoL) assessment in patients with acne is recommended by several national guidelines. There are several acne-specific HRQoL instruments. Participants of the European Academy of Dermatology and Venereology (EADV) Task Forces (TFs) on QoL and Patient Oriented Outcomes (PO) and Acne, Rosacea, and Hidradenitis Suppurativa (ARHS) agreed to scrutinize aspects of existing acne-specific HRQoL instruments for their relevance in international study. Consensus agreement on items related to QoL was reached after an independent assessment by seven experts from the EADV TFs on QoL and PO, and a list of 97 items was prepared and proposed to a group of acne patients. In order to have data from patients to check if any important topics were overseen, another group of acne patients from participating countries was asked to list how acne influenced different aspects of their lives. Based on results obtained from 601 acne patients from nine countries, most of the items and topics showed low relevance for acne patients especially during the previous month or shorter time periods. Based on percentage of relevance and factor analysis, short (6 items) and long (45 items) lists of the most relevant topics were formed. Most of the items and topics from the initial list showed low relevance for acne patients. None of the identified acne-specific HRQoL instruments contain all the items that were deemed most relevant to acne patients. For this reason, participating members of the EADV TFs on QoL and PO, and ARHs are in the process of developing a new acne-specific HRQoL instrument.

Sections du résumé

BACKGROUND BACKGROUND
Health-related quality of life (HRQoL) assessment in patients with acne is recommended by several national guidelines. There are several acne-specific HRQoL instruments.
OBJECTIVES OBJECTIVE
Participants of the European Academy of Dermatology and Venereology (EADV) Task Forces (TFs) on QoL and Patient Oriented Outcomes (PO) and Acne, Rosacea, and Hidradenitis Suppurativa (ARHS) agreed to scrutinize aspects of existing acne-specific HRQoL instruments for their relevance in international study.
METHODS METHODS
Consensus agreement on items related to QoL was reached after an independent assessment by seven experts from the EADV TFs on QoL and PO, and a list of 97 items was prepared and proposed to a group of acne patients. In order to have data from patients to check if any important topics were overseen, another group of acne patients from participating countries was asked to list how acne influenced different aspects of their lives.
RESULTS RESULTS
Based on results obtained from 601 acne patients from nine countries, most of the items and topics showed low relevance for acne patients especially during the previous month or shorter time periods. Based on percentage of relevance and factor analysis, short (6 items) and long (45 items) lists of the most relevant topics were formed.
CONCLUSION CONCLUSIONS
Most of the items and topics from the initial list showed low relevance for acne patients. None of the identified acne-specific HRQoL instruments contain all the items that were deemed most relevant to acne patients. For this reason, participating members of the EADV TFs on QoL and PO, and ARHs are in the process of developing a new acne-specific HRQoL instrument.

Identifiants

pubmed: 36476839
pii: 000526602
doi: 10.1159/000526602
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

267-272

Informations de copyright

© 2022 S. Karger AG, Basel.

Auteurs

Pavel V Chernyshov (PV)

Department of Dermatology and Venereology, National Medical University, Kiev, Ukraine.

Francesca Sampogna (F)

Clinical Epidemiology Unit, Istituto Dermopatico Dell'Immacolata IDI-IRCCS, Rome, Italy.

Christos C Zouboulis (CC)

Department of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences, Brandenburg, Dessau, Germany.

Michael J Boffa (MJ)

Department of Dermatology, Mater Dei Hospital, Msida, Malta.

Servando E Marron (SE)

Department of Dermatology, University Hospital Miguel Servet, Aragon Psychodermatology Research Group Associated to Aragon Health Sciences Institute (IACS), Zaragoza, Spain.

Liana Manolache (L)

Dermatology, Dali Medical, Bucharest, Romania.

Nives Pustišek (N)

Children's Hospital Zagreb, Medical School, University of Zagreb, Zagreb, Croatia.

Vincenzo Bettoli (V)

Section of Dermatology, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.

Dimitra Koumaki (D)

Department of Dermatology and Venereology, University Hospital of Heraklion, Heraklion, Greece.

Olha Chubar (O)

Kiev City Clinical Dermatovenereologic Hospital, Kiev, Ukraine.

Tetiana V Pochynok (TV)

Department of Pediatrics number 1, National Medical University, Kiev, Ukraine.

Dillon Mintoff (D)

Department of Dermatology, Mater Dei Hospital, Msida, Malta.

Nikolaos G Bonitsis (NG)

Department of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences, Brandenburg, Dessau, Germany.
Haut- und Lasercentrum Potsdam-Berlin, Potsdam, Germany.

Saskia Spillekom-van Koulil (S)

Department of Medical Psychology, Radboud University Medical Center Nijmegen, Radboud Institute of Health Sciences, Nijmegen, The Netherlands.

Rieke J B Driessen (RJB)

Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.

Andriy V Chernyshov (AV)

Department of Cellular Radiobiology, State Institution "National Research Center for Radiation Medicine of National Academy of Medical Sciences of Ukraine", Kiev, Ukraine.

Anthony Paul Bewley (AP)

Barts Health NHS Trust, London, UK.
Department of Dermatology, Queen Mary University, London, UK.

Andrea W M Evers (AWM)

Health, Medical, and Neuropsychology Unit, Leiden University, Leiden, The Netherlands.

Ivan P Chernyshov (IP)

Second Medical Faculty, National Medical University, Kiev, Ukraine.

Lucia Tomas-Aragones (L)

Department of Psychology, University of Zaragoza, Aragon Health Sciences Institute (IACS), Zaragoza, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH